We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Biocept, Inc. in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 13 → 0 (-13)

100% less capital invested

Capital invested by funds: $218K → $0 (-$218K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 13

Holders
–
Holders Change
-13
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$147K
2
VF
Virtu Financial
New York
-$17K
3
TSS
Two Sigma Securities
New York
-$15.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$13.1K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
– -$147K -117,647 Closed
VF
2
Virtu Financial
New York
– -$17K -13,777 Closed
TSS
3
Two Sigma Securities
New York
– -$15.9K -12,718 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
– -$13.1K -10,504 Closed
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
– -$13K -10,406 Closed
BlackRock
6
BlackRock
New York
– -$6.58K -5,261 Closed
TRCT
7
Tower Research Capital (TRC)
New York
– -$4.75K -3,802 Closed
Group One Trading
8
Group One Trading
Illinois
– -$338 -270 Closed
UBS Group
9
UBS Group
Switzerland
– -$155 -124 Closed
Osaic Holdings
10
Osaic Holdings
Arizona
– -$41 -33 Closed
US Bancorp
11
US Bancorp
Minnesota
– -$23 -18 Closed
Wells Fargo
12
Wells Fargo
California
– -$14 -11 Closed

BIOC Hedge Fund Activity: Q4 2023 in Review

0 of the 6,862 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2023, worth a combined $0 — down 100% from $218K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BIOC and 0 opened new positions — a net loss of 13 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alyeska Investment Group, exiting entirely with an estimated $147K sold.

  • 0 institutional investors held Biocept, Inc. (BIOC) as of Q4 2023, down from 13 in Q3 2023.
  • Funds reported $0 of Biocept, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Biocept, Inc. positions in Q4 2023 and 13 closed out, a net change of -13 holders.
  • The largest Biocept, Inc. seller in Q4 2023 was Alyeska Investment Group, an estimated $147K sold.

Based on aggregated 13F filings for Q4 2023.